FONTANINI, GABRIELLA
 Distribuzione geografica
Continente #
AS - Asia 43
NA - Nord America 14
SA - Sud America 13
EU - Europa 11
Totale 81
Nazione #
US - Stati Uniti d'America 14
BR - Brasile 13
HK - Hong Kong 12
SG - Singapore 12
CN - Cina 11
NL - Olanda 10
KR - Corea 2
SA - Arabia Saudita 2
ID - Indonesia 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
TR - Turchia 1
Totale 81
Città #
Council Bluffs 12
Cangzhou 6
Ashburn 2
Belo Horizonte 2
Rio de Janeiro 2
Seoul 2
Antalya 1
Arujá 1
Cachoeira do Sul 1
Campinas 1
Cascavel 1
Jakarta 1
João Pessoa 1
Medina 1
Nablus 1
Niterói 1
Năsăud 1
Pelotas 1
Riyadh 1
São Gabriel 1
Vitória da Conquista 1
Totale 41
Nome #
Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer 16
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 12
CIRCULATING AMPHIREGULIN (AR) PLASMA LEVELS AS SURROGATE PHARMACODYNAMIC MARKERS OF EGFR INHIBITION WITH CETUXIMAB IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) 8
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 8
Functional characterization of EZH2 single nucleotide polymorphism and correlation of EZH2 expression with clinico-pathological and molecular parameters in colorectal (CRC) cancer samples 7
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients 7
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo 5
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer 4
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan 4
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 4
Circulating amphiregulin (AR) plasma levels as surrogate pharmacodynamic markers of EGFR inhibition with cetuximab in metastatic colorectal cancer (MCRC) patients 3
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1 3
Totale 81
Categoria #
all - tutte 403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202581 0 0 0 0 0 0 12 14 28 19 8 0
Totale 81